Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMC vs BCG in Non-Muscle-Invasive Bladder Cancer
NCT00974818Phase 3Terminated
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c in non-muscle-invasive bladder cancer (NMIBC), sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 2009; status: terminated.
02
Drugs
mitomycin c
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT00974818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00974818.